NCIARTNet Profile Banner
Acquired Resistance to Therapy Network (ARTNet) Profile
Acquired Resistance to Therapy Network (ARTNet)

@NCIARTNet

Followers
387
Following
494
Media
166
Statuses
568

Official Account of @theNCI Acquired Resistance to Therapy Network (ARTNet). https://t.co/4EHNl98ody

Joined April 2020
Don't wanna be here? Send us removal request.
@NCIARTNet
Acquired Resistance to Therapy Network (ARTNet)
2 years
The Acquired Resistance to Therapy Network (ARTNet), of @theNCI focuses on mechanisms of acquired resistance to cancer therapies & disease recurrence and integrates those findings through team science. Learn more at and
Tweet card summary image
cancer.gov
Acquired Resistance to Therapy Network (ARTNet) focuses on the mechanistic bases of acquired resistance to cancer therapies and disease recurrence. Its goal is to balance basic, pre-clinical, and...
0
1
3
@NCIARTNet
Acquired Resistance to Therapy Network (ARTNet)
7 days
Check out the latest research by ARTNet PI Dr @BoyiGan and his team at @MDAndersonNews linking hypoxia-mediated chromatin regulation to phospholipid metabolism and ferroptosis resistance in cancer. Out now @MolecularCell 👇.
@MolecularCell
Molecular Cell
7 days
A breathless brake on ferroptosis
Tweet media one
0
0
2
@NCIARTNet
Acquired Resistance to Therapy Network (ARTNet)
7 days
RT @CD_AACR: In the Spotlight: Toward Response-Adaptive Therapy in Locally Advanced NSCLC: Integrating ctDNA and Radiomics for Risk Stratif….
0
5
0
@NCIARTNet
Acquired Resistance to Therapy Network (ARTNet)
11 days
RT @Cancer_Cell: Online Now: A pan-KRAS inhibitor and its derived degrader elicit multifaceted anti-tumor efficacy in KRAS-driven cancers h….
0
51
0
@NCIARTNet
Acquired Resistance to Therapy Network (ARTNet)
11 days
New Tools and Resources from the NCI Data Sharing Hub, now available via the ARTNet Shared Resources Catalog. Check out all the NCI/NIH Shared resources at the link below:.To view the ARTNet generated resources please visit:
0
0
1
@NCIARTNet
Acquired Resistance to Therapy Network (ARTNet)
12 days
RT @jsoriamd: #ASCO25 Development of acquired therapeutic resistance limits the efficacy of cancer treatments. How resistance arises, varie….
0
8
0
@NCIARTNet
Acquired Resistance to Therapy Network (ARTNet)
19 days
RT @NatureCancer: 🚨ARTICLE now published @NatureCancer !. ✏️By Valsamo Anagnostou and colleagues. 'Combination of pembrolizumab and radioth….
Tweet card summary image
nature.com
Nature Cancer - Huang et al. analyzed serial samples from participants with metastatic non-small cell lung cancer treated with radiotherapy followed by immunotherapy and report improved clinical...
0
28
0
@NCIARTNet
Acquired Resistance to Therapy Network (ARTNet)
20 days
RT @VRodriguezBravo: Very excited about our last paper in @CD_AACR on the role of off-pore nucleoporins in #prostatecancer progression & im….
0
5
0
@NCIARTNet
Acquired Resistance to Therapy Network (ARTNet)
1 month
RT @NCICAPIT: Don't wait-register now for the CAP-IT Virtual Annual Summit on July 24, 2025! .Open to the public with exciting talks on can….
0
4
0
@NCIARTNet
Acquired Resistance to Therapy Network (ARTNet)
1 month
Reactome is an open-source, peer-reviewed pathway database providing intuitive tools for visualizing and analyzing molecular pathways, advancing research, genomics, and systems biology since 2003. Co-led by Dr. Guanming Wu of the ARTNet U54 center at @OHSUNews. Explore:.
0
1
3
@NCIARTNet
Acquired Resistance to Therapy Network (ARTNet)
1 month
RT @NCICAPIT: This new paper from CAP-IT U24 center @RoswellPark proposes a machine learning-assisted inferential procedure under Rosenbaum….
0
3
0
@NCIARTNet
Acquired Resistance to Therapy Network (ARTNet)
2 months
RT @SeanPitroda: 📢 New in Cancer Cell: Radiotherapy is essential for local control—but can it unintentionally accelerate growth of distant….
0
46
0
@NCIARTNet
Acquired Resistance to Therapy Network (ARTNet)
2 months
RT @EGFRResisters: Osimertinib plus chemotherapy versus osimertinib for patients with advanced NSCLC with concomitant EGFR and TP53 mutatio….
Tweet card summary image
nature.com
Scientific Reports - Osimertinib plus chemotherapy versus osimertinib for patients with advanced NSCLC with concomitant EGFR and TP53 mutations: a prospective cohort study
0
15
0
@NCIARTNet
Acquired Resistance to Therapy Network (ARTNet)
2 months
RT @ImmunityCP: Online now: Mutant p53 exploits enhancers to elevate immunosuppressive chemokine expression and impair immune checkpoint i….
Tweet card summary image
cell.com
Pancreatic ductal adenocarcinoma is an aggressive cancer characterized by an immunosuppressive tumor microenvironment and limited therapeutic options. Mahat et al. show that a prevalent p53 mutation...
0
12
0
@NCIARTNet
Acquired Resistance to Therapy Network (ARTNet)
2 months
RT @Nature: Nature research paper: Nerve-to-cancer transfer of mitochondria during cancer metastasis.
0
167
0
@NCIARTNet
Acquired Resistance to Therapy Network (ARTNet)
2 months
RT @NIH: Are you an early stage researcher? Check out the newly released #FundingOpportunity for the #NIH Director’s New Innovator Award to….
0
45
0
@NCIARTNet
Acquired Resistance to Therapy Network (ARTNet)
2 months
RT @Cancer_Cell: Online Now: Bile acids activate cancer-associated fibroblasts and induce an immunosuppressive microenvironment in cholangi….
0
60
0
@NCIARTNet
Acquired Resistance to Therapy Network (ARTNet)
2 months
@IOTNmoonshot
IOTN Moonshot
2 months
If you use Spearman (or Pearson) correlation p-values from standard software… there's a 99.9% chance they’re wrong. Drs. Han Yu and Alan Hutson @Amherst73 of @RoswellPark reveal why in "A robust Spearman correlation coefficient permutation test" , the top-cited article of the.
0
0
0
@NCIARTNet
Acquired Resistance to Therapy Network (ARTNet)
2 months
RT @NIH: A new study funded by the NIH sheds light on how the 3D organization of #DNA inside the nucleus affects its vulnerability to #chem….
0
26
0